14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Jan 13, 2026
BFLY.WS vs CHEK: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CHEK Wins Head-to-Head Institutional Verdict (2–0 across 6 Pillars · 8–0 Matrix Metrics)
CHEK Overall Winner
6-Pillar Tally: BFLY.WS 0 – 2 CHEK (4 Tie)
Matrix Metrics: BFLY.WS 0 – 8 CHEK
As of Jan 13, 2026, Check-Cap Ltd. (CHEK) is the stronger overall head-to-head candidate over Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of (BFLY.WS) in the Tradestie Institutional Equity Comparison Engine, winning 8–0 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). BFLY.WS carries a Unified Composite Score of 33.5/100 (SELL) at $0.01 (N/M Forward P/E, N/A operating margin), whereas CHEK carries 52.1/100 (HOLD) at $1.61 (N/M Forward P/E, 0.0% operating margin).
Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BFLY.WS vs CHEK. Trailing 12-month operating profitability (BFLY.WS N/A vs CHEK 0.0%) and valuation multiples (BFLY.WS N/M vs CHEK N/M Forward P/E) are benchmarked directly in Pillar 4 below.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus Operator
Competes within the X-Ray Apparatus & Tubes & Related Irradiation Apparatus value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
CHEK Moat ProfileCyclical / Execution-Driven Positioning
X-Ray Apparatus & Tubes & Related Irradiation Apparatus Operator
Competes within the X-Ray Apparatus & Tubes & Related Irradiation Apparatus value chain with $9.2M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ BFLY.WS vs CHEK Key Questions & Quantitative Answers
As of Jan 13, 2026, Check-Cap Ltd. (CHEK) is the stronger overall head-to-head candidate over Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of (BFLY.WS) in the Tradestie Institutional Equity Comparison Engine, winning 8–0 core matrix metrics and 2–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). BFLY.WS carries a Unified Composite Score of 33.5/100 (SELL) at $0.01 (N/M Forward P/E, N/A operating margin), whereas CHEK carries 52.1/100 (HOLD) at $1.61 (N/M Forward P/E, 0.0% operating margin). Technically, BFLY.WS sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure) and CHEK sits in a Neutral phase (RSI 51.0, UNCLASSIFIED options structure).
CHEK leads the Growth & Scale pillar: BFLY.WS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CHEK at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, BFLY.WS generates N/A in USD-normalized revenue versus N/A for CHEK. In operating R&D and SG&A reinvestment, BFLY.WS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CHEK.
BFLY.WS and CHEK trade at balanced relative valuation multiples. BFLY.WS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CHEK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BFLY.WS (N/A ROE) versus CHEK (-226.2% ROE) capital efficiency.
In options market volatility and institutional positioning, BFLY.WS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.95β · 347% Vol realized risk). By comparison, CHEK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.94β · 179% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (BFLY.WS) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Jan 13, 2026. For educational research only; not investment advice.